Cite
HARVARD Citation
Hosomi, Y. et al. (2018). Characteristics and outcomes of patients with EGFR-mutation positive non-small-cell lung cancer receiving gefitinib beyond radiological progression. Expert opinion on pharmacotherapy. pp. 1049-1056. [Online].